astemizole has been researched along with Hyperplasia in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Astemizole was administered with the food to mice for 18 and to rats for 24 consecutive months." | 1.29 | Carcinogenicity studies of astemizole in mice and rats. ( Benze, J; Bowden, C; De Coster, R; Gypen, L; Lampo, A; Van Cauteren, H; Vandenberghe, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benze, J | 1 |
| Gypen, L | 1 |
| Vandenberghe, J | 1 |
| Lampo, A | 1 |
| De Coster, R | 1 |
| Bowden, C | 1 |
| Van Cauteren, H | 1 |
1 other study available for astemizole and Hyperplasia
| Article | Year |
|---|---|
Carcinogenicity studies of astemizole in mice and rats.
Topics: Aging; Animals; Astemizole; Carcinogenicity Tests; Dose-Response Relationship, Drug; Female; Histami | 1995 |